[[Saxagliptin]]

CATEGORIES: Dipeptidyl peptidase-4 inhibitors, Nitriles, Bristol-Myers Squibb, Adamantanes, Alcohols, Amides, Nitrogen heterocycles

Saxagliptin (rINN), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.[ref]
